Skip to content
Showing 21 - 30 of 1498 results.
Dr. Kelly Posner Gerstenhaber says it's especially important for parents, teachers, coaches and friends to ask survivors direct questions about suicidal thoughts.
Dr. J. John Mann says while there are clear short-term benefits to ketamine, its long-term effects, its abuse potential and the optimal number of treatments a patient should receive are still unknown.
“The I.R.B. system is not foolproof. The number of retractions of published research articles is rapidly rising,” writes Dr. Robert Klitzman.
“Richard was very much heterosexual," said Dr. Jack Drescher, "and it took a lot of courage to argue for gay people" in the 1970s.
Go Medical, in collaboration with Columbia University and the New York State Psychiatric Institute, initiated the evaluation of the safety and pharmacokinetics of the OLANI for opioid use disorder.
Columbia Psychiatrists suggest that researchers, pharmaceutical companies, and the FDA reconsider placebo-controlled, relapse prevention studies in schizophrenia.
Dr. Randy Auerbach spoke with BBC World Service about a clinical trial in which his team of researchers are monitoring adolescents at risk of suicide through their smartphones (forward to 43:26).
“There seems to be a general liability factor, which is genetically transmitted, to having a variety of different psychiatric and neurological disorders,” says Dr. Alan Brown.
"This treatment brings in the parents, finally, and focuses on the ways parents need [to stop] taking over, to break the cycle of anxiety in kids," said Dr. Anne Marie Albano.
“Patients receiving the probiotic had a significantly decreased risk of being hospitalized,” writes Dr. Drew Ramsey.